Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free

New Upgrade:   Dedicated Screeners for Stocks & ETFs

Learn more

Neuphoria Therapeutics, Inc.

Contributing Author

Recent Articles by Neuphoria Therapeutics, Inc.

Jun-26
Dec-08
Dec-04
Dec-01
Nov-24
Nov-11
Oct-27
Oct-20
Sep-29
Sep-04
Aug-28
May-27
May-20